MedPath
FDA Approval

Ibuprofen

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
July 12, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ibuprofen(800 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Preferred Pharmaceuticals, Inc.

Preferred Pharmaceuticals, Inc.

Preferred Pharmaceuticals, Inc.

791119022

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ibuprofen

Product Details

NDC Product Code
68788-9112
Application Number
ANDA075682
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 12, 2023
IbuprofenActive
Code: WK2XYI10QMClass: ACTIBQuantity: 800 mg in 1 1
carnauba waxInactive
Code: R12CBM0EIZClass: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4Class: IACT
croscarmellose sodiumInactive
Code: M28OL1HH48Class: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
polydextroseInactive
Code: VH2XOU12IEClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT

Ibuprofen

Product Details

NDC Product Code
68788-9111
Application Number
ANDA075682
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 12, 2023
IbuprofenActive
Code: WK2XYI10QMClass: ACTIBQuantity: 600 mg in 1 1
carnauba waxInactive
Code: R12CBM0EIZClass: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4Class: IACT
croscarmellose sodiumInactive
Code: M28OL1HH48Class: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
polydextroseInactive
Code: VH2XOU12IEClass: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT

Ibuprofen

Product Details

NDC Product Code
68788-9110
Application Number
ANDA075682
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
July 12, 2023
carnauba waxInactive
Code: R12CBM0EIZClass: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4Class: IACT
croscarmellose sodiumInactive
Code: M28OL1HH48Class: IACT
IbuprofenActive
Code: WK2XYI10QMClass: ACTIBQuantity: 400 mg in 1 1
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WOClass: IACT
polydextroseInactive
Code: VH2XOU12IEClass: IACT
magnesium stearateInactive
Code: 70097M6I30Class: IACT
titanium dioxideInactive
Code: 15FIX9V2JPClass: IACT
polysorbate 80Inactive
Code: 6OZP39ZG8HClass: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1AClass: IACT
© Copyright 2025. All Rights Reserved by MedPath